Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART TNT in Locally Advanced Rectal Cancer
NCT05412082Phase 1Recruiting
- Sponsor
- University of Miami
- Start
- Oct 2022
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial in locally advanced rectal cancer (LARC) (2 arms), sponsored by University of Miami. Primary endpoint: Incidence of Toxicity Among Participants After Start Receiving MRI-g Pelvic ART at 30 months. Started Oct 2022; status: recruiting.
02
Conditions
locally advanced rectal cancer (LARC)
Beyond the preview
Go deeper on NCT05412082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05412082.